| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 6 months | ₹30,000 | ₹32,199 | +7.33% | |
| 1 year | ₹60,000 | ₹68,347 | +13.91% | |
| 3 years | ₹1,80,000 | ₹2,32,556 | +29.20% | |
| 5 years | ₹3,00,000 | ₹4,74,724 | +58.24% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 9.68% |
| Eli Lilly Forgn. Eq (LLY) | Healthcare | Foreign - Equity | 7.33% |
| Divi's Laboratories Ltd | Healthcare | Equity | 7.07% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 5.15% |
| Laurus Labs Ltd | Healthcare | Equity | 5.11% |
| Johnson & Johnson Ltd. Forgn. Eq (JNJ) | Healthcare | Foreign - Equity | 4.25% |
| Cipla Ltd | Healthcare | Equity | 4.22% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 4.10% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 3.98% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 3.67% |
| AbbVie Inc Forgn. Eq (ABBV) | Healthcare | Foreign - Equity | 3.36% |
| Lupin Ltd | Healthcare | Equity | 2.78% |
| Aurobindo Pharma Ltd | Healthcare | Equity | 2.64% |
| Merck & Co Inc (US) Forgn. Eq (MRK) | Healthcare | Foreign - Equity | 2.38% |
| Fortis Healthcare Ltd | Healthcare | Equity | 2.28% |
| Glenmark Pharmaceuticals Ltd | Healthcare | Equity | 1.96% |
| Novartis AG ADS/ADR (NVS) | Healthcare | ADS/ADR | 1.90% |
| Thermo Fisher Scientific Inc Forgn. Eq (TMO) | Healthcare | Foreign - Equity | 1.67% |
| Ipca Laboratories Ltd | Healthcare | Equity | 1.63% |
| Amgen Inc. (USA) Forgn. Eq (AMGN) | Healthcare | Foreign - Equity | 1.62% |
| Mankind Pharma Ltd. | Healthcare | Equity | 1.56% |
| Others CBLO | Unspecified | CBLO | 1.43% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.39% |
| Gland Pharma Ltd | Healthcare | Equity | 1.39% |
| Gilead Sciences Inc. (USA) Forgn. Eq (GILD) | Healthcare | Foreign - Equity | 1.37% |
| Alkem Laboratories Ltd | Healthcare | Equity | 1.30% |
| Biocon Ltd | Healthcare | Equity | 1.29% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 1.19% |
| Abbott Laboratories Forgn. Eq (ABT) | Healthcare | Foreign - Equity | 1.19% |
| Intuitive Surgical Inc. (USA) Forgn. Eq (ISRG) | Healthcare | Foreign - Equity | 0.99% |
| Danaher Corporation Forgn. Eq (DHR) | Healthcare | Foreign - Equity | 0.96% |
| Ajanta Pharma Ltd | Healthcare | Equity | 0.93% |
| Vertex Pharmaceuticals Inc. (USA) Forgn. Eq (VRTX) | Healthcare | Foreign - Equity | 0.92% |
| Wockhardt Ltd | Healthcare | Equity | 0.84% |
| Novo Nordisk A/S Forgn. Eq (NVO) | Healthcare | ADS/ADR | 0.83% |
| Medtronic Forgn. Eq (MDT) | Healthcare | Foreign - Equity | 0.80% |
| Stryker Corp Forgn. Eq (SYK) | Healthcare | Foreign - Equity | 0.65% |
| Narayana Hrudayalaya Ltd | Healthcare | Equity | 0.63% |
| Global Health Ltd | Healthcare | Equity | 0.62% |
| Regeneron Pharmaceuticals Inc Forgn. Eq (REGN) | Healthcare | Foreign - Equity | 0.62% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 0.58% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 0.54% |
| Becton Dickinson And Co Forgn. Eq (BDX) | Healthcare | Foreign - Equity | 0.35% |
| Agilent Technologies Inc Forgn. Eq (A) | Healthcare | Foreign - Equity | 0.32% |
| Iqvia Holdings Forgn. Eq (IQV) | Healthcare | Foreign - Equity | 0.29% |
| Waters Corporation (WAT) | Healthcare | Foreign - Equity | 0.29% |
| Cash | Unspecified | Cash | 0.00% |
| Net Payables | Unspecified | Net Payables | -0.05% |
| Name | 1Y | 3Y | 5Y | All |
|---|---|---|---|---|
| Fund returns | +22.0% | +21.2% | +15.1% | +16.6% |
| Category average (Equity Sectoral) | +18.6% | +21.5% | +15.6% | +17.1% |
| Rank (Equity Sectoral) | 10 | 9 | 9 | -- |